PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study proposes streamlined approach to developing cancer drugs

Findings suggest placement of molecular linkers should be determined earlier on in drug discovery

Study proposes streamlined approach to developing cancer drugs
2024-02-28
(Press-News.org) BUFFALO, N.Y. — Drug discovery can be a frustrating process of trial and error.

Scientists using fragment-based drug discovery link fragments of different molecules together to create a more potent drug but may not know whether a compound works until millions of dollars in research and development have already been spent.

New University at Buffalo research may offer a more streamlined approach, allowing drug makers to determine the viability of a fragment-based design earlier in the process. 

While developing a fragment-based drug to treat lung cancer, a team co-led by UB found that where they linked fragments together had a large effect on potency.

“Despite consisting of the same molecule fragments, we found that one of our compounds was superadditive, while the other was virtually inactive. The main difference between the two was the points at which their fragments were linked together,” says David Heppner, PhD, Jere Solo Assistant Professor of medicinal chemistry in the UB College of Arts and Sciences and co-senior author of the study, which published Feb. 20 in Communications Chemistry, an open-access Nature Portfolio Journal.

Molecule fragments are often linked together using another molecule, typically called linkers. Much attention is paid to their length and the kinds of atoms inside, while their placement on fragments, or the points of connection, is often left up to chance.

But Heppner and his team say that determining the optimal point of connection at the onset, while perhaps cumbersome, is most efficient.

“We believe our approach adds more intelligence to the drug optimization process and minimizes the amount of work needed to find the most potent structure,” says co-lead author Blessing Ogboo, a PhD student in Heppner’s lab.

The stakes are high in drug discovery: It’s estimated that it takes on average 12 years and $2.7 billion to develop a new drug. Most drugs never even make it to the market — for example, 97% of cancer drugs fail clinical trials.

Fragment-based drug discovery, or FBDD, has become a sought-after method. Linked fragments can bind to a drug target, like a protein or enzyme, at multiple sites simultaneously, making them more potent than their parent molecules would be on their own.

The UB team was using FBDD to develop inhibitors that can bind to multiple sites on the kinase domain of the epidermal growth factor receptor (EGFR), a key protein in non-small cell lung cancer. One of their inhibitors was linked to a central group, while the other was connected through an outer region of the molecule.

When tested on an EGFR in a cell culture, the inhibitor linked through an outer region was more than 1 million times more potent.

Curious to understand why, the team used x-ray crystallography and molecular dynamic simulations to determine the two inhibitors’ 3-D structure and how they bind to EGFR. 

The tools showed that the superior potency was due to the placement of its linker allowing for greater mobility and better compatibility with the EGFR’s binding site. They also ruled out more conventional attributes — length and atom type — being behind the increased potency.

“Previous studies have highlighted the importance of flexibility for linkers, but we believe our inhibitors are unique given their wide range of potency despite relatively small differences in linker structure,” says co-lead author Stefan Laufer, PhD, of the Eberhard Karls University of Tübingen.

Other co-authors from UB include Tahereh Damghani, PhD, a postdoctoral research associate; Surbhi Chitnis, a PhD student; and former graduate students Calvin Pham and Brandon Oligny. Other contributors represent Roswell Park Comprehensive Cancer Center, Harvard Medical School, the University of Eastern Finland, and AssayQuant Technologies, Inc.

Heppner and Laufer’s teams have filed both a U.S. and international patent application on the EGFR inhibitors and are working with UB’s Technology Transfer office.

The Heppner lab recently led another study on covalent EGFR inhibitors that was published in the Journal of Medicinal Chemistry. Written in collaboration industry partners, it serves as a perspective on best practices, as well as common pitfalls in drug development.

“We hope our recent studies and others like them can better inform decision making in the drug discovery process, creating cost savings and decreasing time to new therapies,” Heppner says.

Both studies were supported by the National Institutes of Health. 

END

[Attachments] See images for this press release:
Study proposes streamlined approach to developing cancer drugs

ELSE PRESS RELEASES FROM THIS DATE:

New study finds high-dose inhaled nitric oxide decreases the risk of death among critically ill Black patients with COVID-19

2024-02-28
In a first-of-its-kind study published in the American Journal of Respiratory and Critical Care Medicine, physician-scientists from the University of Alabama at Birmingham Marnix E. Heersink School of Medicine discovered that high-dose inhaled nitric oxide therapy may improve oxygenation and reduce the risk of mortality among critically ill Black patients with COVID-19. Acute respiratory distress syndrome, or ARDS, is a condition that most commonly occurs in the setting of a lung infection such as COVID-19. “In ARDS, the barrier between the blood vessels and air sacs in the lungs is disrupted leading to the accumulation of fluid ...

Ochsner Digital Medicine Partners with Humana Healthy Horizons

Ochsner Digital Medicine Partners with Humana Healthy Horizons
2024-02-28
New Orleans, LA. – Ochsner Digital Medicine has partnered with Humana Healthy Horizons to provide digital medicine services to its members. This agreement was effective February 1, 2024, with member enrollment in digital programs available immediately after. Humana Healthy Horizons is Humana’s Medicaid plan for Louisiana, covering thousands of members throughout the state. Through this partnership, Ochsner Digital Medicine will offer Humana Healthy Horizons members who have been diagnosed with Hypertension and Type 2 diabetes remote programs designed to manage and control their conditions. The programs use remote patient management through digital devices and personalized ...

Vision Zero road safety projects in Seattle are unlikely to have negative impacts on local business sales, UW study finds

2024-02-28
Seattle is routinely listed as one of the most walkable and bike-friendly cities in the nation. The city government has committed to Vision Zero, which aims to completely eliminate traffic deaths and serious injuries by 2030, and embarked on a slew of infrastructure projects: expanding the city’s bike network, redesigning high-crash intersections and enhancing crosswalks to protect pedestrians.  Such safety projects sometimes meet opposition from local business owners, who worry that reduced parking and disruption ...

African great apes predicted to see frequent extreme climate events in the next 30 years

African great apes predicted to see frequent extreme climate events in the next 30 years
2024-02-28
African apes are already being exposed to climate change impacts, and will experience extreme events such as wildfires, heatwaves and flooding more frequently in the next 30 years, according to a study publishing February 28 in the open-access journal PLOS Climate by Razak Kiribou at Haramaya University in Ethiopia and colleagues. To better understand how African great apes will be affected by climate change, researchers investigated past and future climate for 363 sites across Africa. They estimated temperature and rainfall at each site between 1981 and 2010. Using two climate change scenarios, they projected how frequently apes would be exposed to climate change impacts in the near ...

EU countries have seen a decade of progress towards their 2030 sustainable energy goal

EU countries have seen a decade of progress towards their 2030 sustainable energy goal
2024-02-28
Countries in the European Union (EU) have made progress over the past decade toward Sustainable Development Goal 7 (SDG 7), which calls for “access to affordable, reliable, sustainable and modern energy for all” by 2030, according to a study published February 28, 2024 in the open-access journal PLOS ONE by Marek Walesiak from Wroclaw University of Economics and Business, Poland, and Grażyna Dehnel from Poznań University of Economics and Business, Poland. In 2015, the United Nations developed 17 global Sustainable Development Goals to be achieved by 2030. Tenets of SDG 7 include universal access to affordable energy; increased renewable energy ...

Climate change threatens thousands of archaeological sites in coastal Georgia

Climate change threatens thousands of archaeological sites in coastal Georgia
2024-02-28
Thousands of historic and archaeological sites in Georgia are at risk from tropical storm surges, and that number will increase with climate change, according to a study published February 28, 2024 in the open-access journal PLOS ONE by Matthew D. Howland and Victor D. Thompson of Wichita State University and the University of Georgia. Anthropogenic climate change poses a major risk to coastlines due to rising sea level and increasingly severe tropical storms. This threatens not only living populations but also historic and archaeological sites. Mitigating damage requires accurate assessments of risks, but most predictive models focus on projected ...

Pet dogs with diarrhea may be shedding multi-drug resistant E.coli in 5 in 10 cases, with potential risks to their human owners

Pet dogs with diarrhea may be shedding multi-drug resistant E.coli in 5 in 10 cases, with potential risks to their human owners
2024-02-28
Pet dogs with diarrhea may be shedding multi-drug resistant E.coli in 5 in 10 cases, with potential risks to their human owners ### Article URL:  https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0298053 Article Title: Characteristics of MDR E. coli strains isolated from Pet Dogs with clinic diarrhea: A pool of antibiotic resistance genes and virulence-associated genes Author Countries: China Funding: This research was funded by the National Key Research and Development Program of China (2018YFD0500900, ...

Harassment on public transport negatively impacts women's health and welfare, with existing measures being largely ineffective, per systematic review

Harassment on public transport negatively impacts womens health and welfare, with existing measures being largely ineffective, per systematic review
2024-02-28
Harassment on public transport negatively impacts women's health and welfare, with existing measures being largely ineffective, per systematic review ### Article URL:  https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0296830 Article Title: Invasion of privacy or structural violence? Harassment against women in public transport environments: A systematic review Author Countries: Spain Funding: This study has been supported by the research grant ACIF/2020/035 from the "Generalitat Valenciana". The funding entity did not contribute to the study design or data collection, analysis, interpretation, or writing the manuscript. There was no additional ...

How the SARS-CoV-2 virus acquires its spherical shape

How the SARS-CoV-2 virus acquires its spherical shape
2024-02-28
RIVERSIDE, Calif. -- For centuries, coronaviruses have triggered health crises and economic challenges, with SARS-CoV-2, the coronavirus that spreads COVID-19, being a recent example. One small protein in SARS-CoV-2, the Membrane protein, or M protein, is the most abundant and plays a crucial role in how the virus acquires its spherical structure. Nonetheless, this protein’s properties are not well understood. A research team led by a physicist at the University of California, Riverside, has devised a new method to make large quantities of M protein, and has characterized the protein’s ...

A step toward personalized immunotherapy for all

A step toward personalized immunotherapy for all
2024-02-28
LA JOLLA, CA—Most cancers are thought to evade the immune system. These cancers don't carry very many mutations, and they aren’t infiltrated by cancer-fighting immune cells. Scientists call these cancers immunologically "cold." Now new research suggests such cancers aren't as "cold" as once thought. Researchers from the La Jolla Institute for Immunology (LJI), UC San Diego Moores Cancer Center, and UC San Diego, have found that patients with "cold" tumors actually do make cancer-fighting T cells.  This discovery opens the door to developing vaccines or therapies to increase T cell ...

LAST 30 PRESS RELEASES:

European Hormone Day 2024: Endocrine community unites to raise public awareness and push for policy action on hormone health

Good heart health in middle age may preserve brain function among Black women as they age

The negative effects of racism impact sleep in adolescents

Study uses wearable devices to examine 3- to 6-year-olds’ impulsivity, inattentiveness

Will future hurricanes compromise New England forests’ ability to store and sequester carbon?

Longest study to date assesses cognitive impairment over time in adults with essential tremor

Does a woman’s heart health affect cognition in midlife?

Unveiling the mysteries of cell division in embryos with timelapse photography

Survey finds loneliness epidemic runs deep among parents

Researchers develop high-energy-density aqueous battery based on halogen multi-electron transfer

Towards sustainable food systems: global initiatives and innovations

Coral identified as oldest bioluminescent organism, suggesting a new model of ancient ecology

SRI chosen by DARPA to develop next-generation computational design of metallic parts and intelligent testing of alloys

NJIT engineers muffle invading pathogens with a 'molecular mask'

Perinatal transmission of HIV can lead to cognitive deficits

The consumption of certain food additive emulsifiers could be associated with the risk of developing type 2 diabetes

New cancer research made possible as Surrey scientists study lipids cell by cell 

Bioluminescence first evolved in animals at least 540 million years ago

Squids’ birthday influences mating

Star bars show Universe’s early galaxies evolved much faster than previously thought

Critical minerals recovery from electronic waste

The move by Apple Memories to block potentially upsetting content illustrates Big Tech’s reach and limits, writes Chrys Vilvang

Chemical tool illuminates pathways used by dopamine, opioids and other neuronal signals

Asian monsoon lofts ozone-depleting substances to stratosphere

PET scans reveal ‘smoldering’ inflammation in patients with multiple sclerosis

Genetics predict type 2 diabetes risk and disparities in childhood cancer survivors

Health information on TikTok: The good, the bad and the ugly

New study points to racial and social barriers that block treatment for multiple myeloma

Rensselaer researcher finds that frog species evolved rapidly in response to road salts

A new chapter in quantum vortices: Customizing electron vortex beams

[Press-News.org] Study proposes streamlined approach to developing cancer drugs
Findings suggest placement of molecular linkers should be determined earlier on in drug discovery